ARL2 activators comprise a diverse array of chemical compounds that facilitate the enhancement of ARL2 protein function, a member of the ADP-ribosylation factor family of GTP-binding proteins. ARL2 is implicated in a variety of cellular processes including microtubule dynamics, where it interacts with tubulin-folding cofactors, and mitochondrial stability. The activation of ARL2 is often mediated through the binding and hydrolysis of GTP, which induces a conformational change resulting in its active state. Some activators function by stabilizing the GTP-bound form of ARL2, thereby upholding its active configuration and promoting its interactions with target proteins. For instance, certain guanine nucleotide exchange factors (GEFs) may act as indirect activators of ARL2 by facilitating the exchange of GDP for GTP on the ARL2 protein, thus maintaining it in a GTP-bound and active state.
Additionally, specific chemical activators may enhance the activity of ARL2 by preventing GTP hydrolysis, thereby extending the active time frame of the protein. These compounds might function by binding to the ARL2-GTP complex and stabilizing it against GTPase-activating proteins (GAPs) that would otherwise catalyze the hydrolysis of GTP to GDP, rendering ARL2 inactive. Furthermore, activators may also operate by modulating the interaction of ARL2 with its effectors and partners, such as the ARL2-binding protein BART, which is essential for the proper function of ARL2 in maintaining mitochondrial integrity. By ensuring a more robust interaction with such partners, activators can potentiate the role of ARL2 in cellular processes. The mechanisms by which these activators enhance ARL2 function are critical for the proper regulation of the biological pathways in which this GTPase is involved, underlining the importance of the precise modulation of ARL2's activity within the cell.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A inhibits the GTPase-activating protein (GAP) activity of ELMOD2 towards ARL2, which leads to increased levels of GTP-bound ARL2, thus enhancing its functional activity in cellular trafficking processes. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium levels, which can activate calmodulin and may affect ARL2's interaction with its effectors by altering the calcium-dependent cellular signaling, thus potentially enhancing ARL2 activity. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG inhibits a variety of kinases, which may lead to reduced phosphorylation of ARL2's GAPs and GEFs, potentially resulting in increased ARL2-GTP levels and thus enhanced functional activity of ARL2. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate can activate sphingosine kinase, which may influence ARL2 activity by modulating the lipid environment of cellular membranes where ARL2 exerts its function, leading to enhanced ARL2 activity. | ||||||
Sodium nitroprusside dihydrate | 13755-38-9 | sc-203395 sc-203395A sc-203395B | 1 g 5 g 100 g | $43.00 $85.00 $158.00 | 7 | |
Nitric oxide can S-nitrosylate cysteine residues on proteins, potentially modifying the activity of ARL2 or its interacting partners, thereby indirectly enhancing the functional activity of ARL2. | ||||||
Farnesol | 4602-84-0 | sc-204748 sc-204748A | 50 ml 100 ml | $281.00 $374.00 | 2 | |
Farnesol is involved in the prenylation of proteins like ARL2. Enhanced prenylation can increase membrane association of ARL2, potentially upregulating its functional activity in cellular processes. | ||||||
Geranylgeranylpyrophosphate triammonium salt | 6699-20-3 | sc-200849 | 200 µg | $122.00 | ||
Geranylgeranyl pyrophosphate is a substrate for protein geranylgeranyltransferase, which prenylates ARL2, increasing its membrane localization and function in cellular trafficking. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Paclitaxel stabilizes microtubules and can thereby affect the dynamics of microtubule-associated proteins, including those interacting with ARL2, potentially enhancing its role in microtubule-dependent processes. | ||||||
ML 141 | 71203-35-5 | sc-362768 sc-362768A | 5 mg 25 mg | $137.00 $512.00 | 7 | |
ML141 inhibits Cdc42, a Rho GTPase. While not directly affecting ARL2, the inhibition of Cdc42 can lead to compensatory activation of related GTPases like ARL2, thus indirectly enhancing its activity in cytoskeletal organization. | ||||||